There was a significant increase in the number of investors who held short positions in MKS Instruments, Inc. during November (NASDAQ: MKSI). As of November 30, a total of 2,150,000 shares were available to be sold short. The total number of shares that were available the day before was 1,790,000. This represents an increase of 20.1% from that number. As a result, the days-to-cover ratio currently stands at 2.8 days. This figure was arrived at by considering that the daily trading volume for shares is, on average, 758,200.
On November 2, MKS Instruments (NASDAQ: MKSI) disclosed the outcomes of its most recent financial report covering the preceding quarter. The manufacturer of scientific and technical instruments reported earnings of $2.74 per share for the quarter, which is $0.36 more than the consensus estimate of $2.38 from industry analysts. MKS Instruments achieved a return on equity of 19.14%, and the net margin for the company was 13.31%. The company’s revenue for the previous three months came in at $954 million, which is less than the $954.15 million analysts in this market had anticipated it would bring in. According to the forecasts of specialists in equity research, MKS Instruments will bring in a profit of $9.16 per share during the current financial year.
In addition, the business disclosed that it would be paying a quarterly dividend to its shareholders on December 9 of this year. The payment was made. On Monday, November 28, shareholders of record were each given a dividend payment of $0.22. This payment was made. On November 25, shareholders will no longer be eligible to receive a dividend payment for this payment. This results in a yield of 1.07% and a dividend payment of $0.88 each year as a consequence of what happens as a result of this. The existing dividend payout ratio for MKS Instruments is 11.47 percent, which currently stands at that value.
On Friday, the price of a single share of MKSI stock opened for trading at $82.25, which remained unchanged throughout the day. The price of MKS Instruments has fluctuated wildly over the past year, reaching an all-time low of $64.77 and an all-time high of $181.03. The price of MKS Instruments has fluctuated wildly over the past year, reaching an all-time low of $64.77 and an all-time high of $181.03. There is 1.18 times as much debt as equity, corresponding to a quick ratio of 1.81 and a current ratio of 2.76. The stock’s current price-to-earnings ratio is 10.72, and its beta value is 1.52, giving it a market value of $5.47 billion. The company’s 50-day moving average is currently at $78.89, and its 200-day moving average is currently at $95.08, respectively.
Recently, several equity research analysts were asked for their opinions on the MKSI stock, and they provided their responses.
In a report published on Thursday, Cowen increased their price objective on MKS Instruments, moving it from $85.00 to $100.00. The previous price objective was $85.00. In a report published on Thursday, Cowen increased their price objective on MKS Instruments, moving it from $85.00 to $100.00. The previous price objective was $85.00. Citigroup lowered their price target for MKS Instruments from $140.00 to $100.00 and rated the stock as a “buy” in a research report published on Friday, November 4. The report was about MKS Instruments. In addition, the report recommended “buying” the company’s stock. DA Davidson disclosed on Thursday that they had increased their price objective on MKS Instruments from $90.00 to $100.00, announced in a report published on Thursday. In a research note published on Thursday, Barclays upgraded MKS Instruments from an “equal weight” rating to an “overweight” rating and raised their price target for the company’s stock from $70.00 to $80.00. These changes were made in conjunction with an increase in the price target for the stock. Five research analysts have given the company a recommendation to buy their stock; four research analysts have recommended that the company’s stock be held, and one research analyst has recommended that the company’s stock be sold. According to Bloomberg, the most common recommendation for the company is “Hold,” and the current consensus target price for the company is set at $128.33.
In the past few months, we’ve seen several large investors adjust the MKSI stock they own, which brings us to our next point. Carlyle Group Inc. increased its stake in MKS Instruments by purchasing an additional position during the third quarter, bringing the total value of the company’s investment to approximately $280,405,000. During the second quarter, Victory Capital Management Inc. increased its holding of MKS Instruments to 57.5% of its shares, making it its largest shareholder. In the most recent quarter, Victory Capital Management Inc. bought an additional 956,015 shares of the scientific and technical instruments company’s stock, bringing its total shares to 2,618,232. This gives the company’s stock a value of $268,709,000. During the company’s third fiscal quarter, there was a 16.4% increase in the value of the holdings that Vanguard Group Inc. had in MKS Instruments. Vanguard Group Inc. now has 6,129,843 shares of the scientific and technical instruments company’s stock after purchasing an additional 864,178 shares during the most recent quarter. The stock currently has an estimated market value of $506,575,000. During the second quarter, the value of MKS Instruments in the investment portfolio managed by Polaris Capital LLC increased by 13,965.9%. In the scientific and technical instrument company, Polaris Capital Management LLC is now the owner of 745,494 shares. As a result of the most recent acquisition of 740,194 of the company’s shares during the most recent quarter, the value of these shares has increased to $63,740,000. A 66.8 percent increase in the amount of MKS Instruments stock that Cooke & Bieler LP owned as of the end of the second quarter is the last but not least important development. After making additional purchases totaling 547,410 shares over the most recent quarter, Cooke & Bieler LP is now the owner of 1,366,598 shares in the scientific and technical equipment company. The value of these shares on the market as of right now is $140,254,000. In addition, 96.01 hedge funds and other institutional investors own a percent of the company’s common stock.